{
  "usdmVersion": "4.0",
  "generatedAt": "2025-11-27T18:05:32.735117",
  "generator": "Protocol2USDM v6.0",
  "study": {
    "studyTitles": [
      {
        "id": "title_1",
        "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Brief Study Title",
          "codeSystem": "USDM",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "studyIdentifiers": [
      {
        "id": "id_1",
        "text": "NCT04573309",
        "scopeId": "org_ct_gov",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "id_2",
        "text": "ALXN1840-WD-204",
        "scopeId": "org_1",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "id_3",
        "text": "2020-001104-41",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "id_4",
        "text": "119006",
        "scopeId": "org_2",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Alexion Pharmaceuticals, Inc.",
        "type": {
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "decode": "Pharmaceutical Company"
        },
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "US Food and Drug Administration (FDA)",
        "type": {
          "code": "Government Institute",
          "codeSystem": "USDM",
          "decode": "Government Institute"
        },
        "instanceType": "Organization"
      }
    ],
    "studyPhase": {
      "code": "Phase 2",
      "codeSystem": "USDM",
      "decode": "Phase 2"
    },
    "indications": [
      {
        "id": "indication_1",
        "name": "Wilson Disease",
        "isRareDisease": true,
        "instanceType": "Indication",
        "description": "A study to assess copper and molybdenum balance in participants with Wilson Disease treated with ALXN1840."
      }
    ]
  },
  "studyDesigns": [
    {
      "id": "sd_1",
      "instanceType": "InterventionalStudyDesign",
      "blindingSchema": {
        "code": "C82639",
        "codeSystem": "NCI",
        "decode": "Open Label Study"
      },
      "randomizationType": {
        "code": "Non-Randomized"
      },
      "studyArms": [
        {
          "id": "arm_1",
          "name": "ALXN1840 15 mg/day",
          "type": {
            "code": "Experimental Arm",
            "codeSystem": "USDM",
            "decode": "Experimental Arm"
          },
          "instanceType": "StudyArm",
          "description": "Participants will be initiated on 15 mg/day of ALXN1840 for a treatment period of approximately 28 days."
        },
        {
          "id": "arm_2",
          "name": "ALXN1840 30 mg/day",
          "type": {
            "code": "Experimental Arm",
            "codeSystem": "USDM",
            "decode": "Experimental Arm"
          },
          "instanceType": "StudyArm",
          "description": "Following the 15 mg/day period, participants are titrated up to 30 mg/day on Day 29."
        }
      ],
      "studyCohorts": [
        {
          "id": "cohort_1",
          "name": "Cohort 1 (treatment experienced)",
          "instanceType": "StudyCohort",
          "characteristic": "Patients who have received WD therapy for > 28 days"
        },
        {
          "id": "cohort_2",
          "name": "Cohort 2 (treatment naïve)",
          "instanceType": "StudyCohort",
          "characteristic": "Patients who have received WD therapy for ≤ 28 days"
        }
      ],
      "studyCells": [
        {
          "id": "cell_1",
          "armId": "arm_1",
          "epochId": "epoch_1",
          "elementIds": [],
          "instanceType": "StudyCell"
        },
        {
          "id": "cell_2",
          "armId": "arm_1",
          "epochId": "epoch_2",
          "elementIds": [],
          "instanceType": "StudyCell"
        },
        {
          "id": "cell_3",
          "armId": "arm_1",
          "epochId": "epoch_3",
          "elementIds": [],
          "instanceType": "StudyCell"
        },
        {
          "id": "cell_4",
          "armId": "arm_2",
          "epochId": "epoch_1",
          "elementIds": [],
          "instanceType": "StudyCell"
        },
        {
          "id": "cell_5",
          "armId": "arm_2",
          "epochId": "epoch_2",
          "elementIds": [],
          "instanceType": "StudyCell"
        },
        {
          "id": "cell_6",
          "armId": "arm_2",
          "epochId": "epoch_3",
          "elementIds": [],
          "instanceType": "StudyCell"
        }
      ],
      "eligibilityCriteria": [
        {
          "id": "ec_i1",
          "identifier": "I1",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i1",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 1",
          "nextId": "ec_i2"
        },
        {
          "id": "ec_i2",
          "identifier": "I2",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i2",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 2",
          "previousId": "ec_i1",
          "nextId": "ec_i3"
        },
        {
          "id": "ec_i3",
          "identifier": "I3",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i3",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 3",
          "previousId": "ec_i2",
          "nextId": "ec_i4"
        },
        {
          "id": "ec_i4",
          "identifier": "I4",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i4",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 4",
          "previousId": "ec_i3",
          "nextId": "ec_i5"
        },
        {
          "id": "ec_i5",
          "identifier": "I5",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i5",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 5",
          "previousId": "ec_i4",
          "nextId": "ec_i6"
        },
        {
          "id": "ec_i6",
          "identifier": "I6",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i6",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 6",
          "previousId": "ec_i5",
          "nextId": "ec_i7"
        },
        {
          "id": "ec_i7",
          "identifier": "I7",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i7",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 7",
          "previousId": "ec_i6",
          "nextId": "ec_i8"
        },
        {
          "id": "ec_i8",
          "identifier": "I8",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i8",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 8",
          "previousId": "ec_i7",
          "nextId": "ec_i9"
        },
        {
          "id": "ec_i9",
          "identifier": "I9",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i9",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 9",
          "previousId": "ec_i8",
          "nextId": "ec_i10"
        },
        {
          "id": "ec_i10",
          "identifier": "I10",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i10",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 10",
          "previousId": "ec_i9",
          "nextId": "ec_i11"
        },
        {
          "id": "ec_i11",
          "identifier": "I11",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i11",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 11",
          "previousId": "ec_i10",
          "nextId": "ec_i12"
        },
        {
          "id": "ec_i12",
          "identifier": "I12",
          "category": {
            "code": "C25532",
            "codeSystem": "NCI",
            "decode": "Inclusion Criteria"
          },
          "criterionItemId": "eci_i12",
          "instanceType": "EligibilityCriterion",
          "name": "Inclusion Criterion 12",
          "previousId": "ec_i11"
        },
        {
          "id": "ec_e1",
          "identifier": "E1",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e1",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 1",
          "nextId": "ec_e2"
        },
        {
          "id": "ec_e2",
          "identifier": "E2",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e2",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 2",
          "previousId": "ec_e1",
          "nextId": "ec_e3"
        },
        {
          "id": "ec_e3",
          "identifier": "E3",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e3",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 3",
          "previousId": "ec_e2",
          "nextId": "ec_e4"
        },
        {
          "id": "ec_e4",
          "identifier": "E4",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e4",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 4",
          "previousId": "ec_e3",
          "nextId": "ec_e5"
        },
        {
          "id": "ec_e5",
          "identifier": "E5",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e5",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 5",
          "previousId": "ec_e4",
          "nextId": "ec_e6"
        },
        {
          "id": "ec_e6",
          "identifier": "E6",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e6",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 6",
          "previousId": "ec_e5",
          "nextId": "ec_e7"
        },
        {
          "id": "ec_e7",
          "identifier": "E7",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e7",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 7",
          "previousId": "ec_e6",
          "nextId": "ec_e8"
        },
        {
          "id": "ec_e8",
          "identifier": "E8",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e8",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 8",
          "previousId": "ec_e7",
          "nextId": "ec_e9"
        },
        {
          "id": "ec_e9",
          "identifier": "E9",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e9",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 9",
          "previousId": "ec_e8",
          "nextId": "ec_e10"
        },
        {
          "id": "ec_e10",
          "identifier": "E10",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e10",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 10",
          "previousId": "ec_e9",
          "nextId": "ec_e11"
        },
        {
          "id": "ec_e11",
          "identifier": "E11",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e11",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 11",
          "previousId": "ec_e10",
          "nextId": "ec_e12"
        },
        {
          "id": "ec_e12",
          "identifier": "E12",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e12",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 12",
          "previousId": "ec_e11",
          "nextId": "ec_e13"
        },
        {
          "id": "ec_e13",
          "identifier": "E13",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e13",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 13",
          "previousId": "ec_e12",
          "nextId": "ec_e14"
        },
        {
          "id": "ec_e14",
          "identifier": "E14",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e14",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 14",
          "previousId": "ec_e13",
          "nextId": "ec_e15"
        },
        {
          "id": "ec_e15",
          "identifier": "E15",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e15",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 15",
          "previousId": "ec_e14",
          "nextId": "ec_e16"
        },
        {
          "id": "ec_e16",
          "identifier": "E16",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e16",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 16",
          "previousId": "ec_e15",
          "nextId": "ec_e17"
        },
        {
          "id": "ec_e17",
          "identifier": "E17",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e17",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 17",
          "previousId": "ec_e16",
          "nextId": "ec_e18"
        },
        {
          "id": "ec_e18",
          "identifier": "E18",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e18",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 18",
          "previousId": "ec_e17",
          "nextId": "ec_e19"
        },
        {
          "id": "ec_e19",
          "identifier": "E19",
          "category": {
            "code": "C25370",
            "codeSystem": "NCI",
            "decode": "Exclusion Criteria"
          },
          "criterionItemId": "eci_e19",
          "instanceType": "EligibilityCriterion",
          "name": "Exclusion Criterion 19",
          "previousId": "ec_e18"
        }
      ],
      "studyDesignPopulation": {
        "id": "pop_1",
        "name": "Study Population",
        "includesHealthySubjects": false,
        "criterionIds": [
          "ec_i1",
          "ec_i2",
          "ec_i3",
          "ec_i4",
          "ec_i5",
          "ec_i6",
          "ec_i7",
          "ec_i8",
          "ec_i9",
          "ec_i10",
          "ec_i11",
          "ec_i12",
          "ec_e1",
          "ec_e2",
          "ec_e3",
          "ec_e4",
          "ec_e5",
          "ec_e6",
          "ec_e7",
          "ec_e8",
          "ec_e9",
          "ec_e10",
          "ec_e11",
          "ec_e12",
          "ec_e13",
          "ec_e14",
          "ec_e15",
          "ec_e16",
          "ec_e17",
          "ec_e18",
          "ec_e19"
        ],
        "instanceType": "StudyDesignPopulation",
        "plannedMinimumAge": "18 years",
        "plannedSex": [
          {
            "code": "Male",
            "codeSystem": "USDM",
            "decode": "Male"
          },
          {
            "code": "Female",
            "codeSystem": "USDM",
            "decode": "Female"
          }
        ]
      },
      "objectives": [
        {
          "id": "obj_pri_1",
          "name": "Primary Objective 1",
          "text": "Assess net copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with Wilson disease (WD)",
          "level": {
            "code": "C98772",
            "codeSystem": "NCI",
            "decode": "Primary Objective"
          },
          "endpointIds": [
            "ep_1"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_1",
          "name": "Secondary Objective 1",
          "text": "Assess change in copper balance in response to ALXN1840 15 mg/day and 30 mg/day during ALXN1840 accumulation and at steady state periods versus the pretreatment baseline in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_2"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_2",
          "name": "Secondary Objective 2",
          "text": "Investigate the effect of ALXN1840 (15 mg/day and 30 mg/day) on the disposition of copper in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_3"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_3",
          "name": "Secondary Objective 3",
          "text": "Investigate the effect of ALXN1840 on the disposition of molybdenum at steady state at 15 mg/day and 30 mg/day in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_4"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_4",
          "name": "Secondary Objective 4",
          "text": "Assess steady-state total molybdenum balance as a measure of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_5"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_5",
          "name": "Secondary Objective 5",
          "text": "Assess accumulation of molybdenum with ALXN1840 treatment at 15 mg/day and 30 mg/day in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_6"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_6",
          "name": "Secondary Objective 6",
          "text": "Determine the steady-state plasma pharmacokinetic (PK) of total molybdenum and plasma ultrafiltrate (PUF) molybdenum (as surrogate measures of ALXN1840, 15 mg and 30 mg) in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_7"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_sec_7",
          "name": "Secondary Objective 7",
          "text": "Evaluate the safety and tolerability of repeated-dose administration of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "endpointIds": [
            "ep_8"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_exp_1",
          "name": "Exploratory Objective 1",
          "text": "Determine dose response of ALXN1840 15 mg/day and 30 mg/day for copper balance in participants with WD",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "endpointIds": [
            "ep_9"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_exp_2",
          "name": "Exploratory Objective 2",
          "text": "Determine the effect of treatment duration on copper balance in participants with WD",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "endpointIds": [
            "ep_10"
          ],
          "instanceType": "Objective"
        },
        {
          "id": "obj_exp_3",
          "name": "Exploratory Objective 3",
          "text": "Assess the effects of ALXN1840 on ceruloplasmin, ceruloplasmin-bound copper LBC profiles in plasma in participants with WD",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "endpointIds": [
            "ep_11"
          ],
          "instanceType": "Objective"
        }
      ],
      "endpoints": [
        {
          "id": "ep_1",
          "name": "Primary Endpoint 1",
          "text": "Mean daily copper balance where copper balance is measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) during ALXN1840 accumulation and steady-state periods for each dose",
          "level": {
            "code": "C98772",
            "codeSystem": "NCI",
            "decode": "Primary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Efficacy",
          "objectiveId": "obj_pri_1"
        },
        {
          "id": "ep_2",
          "name": "Secondary Endpoint 2",
          "text": "Change in mean daily copper balance as measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) from pretreatment baseline (Days -4 through -1) and ALXN1840 accumulation and steady-state periods for each dose",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Efficacy",
          "objectiveId": "obj_sec_1"
        },
        {
          "id": "ep_3",
          "name": "Secondary Endpoint 3",
          "text": "Copper quantified in food, drink, feces, and urine, including plasma total and labile bound copper (LBC) during ALXN1840 accumulation and steady-state periods for each dose",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacodynamic",
          "objectiveId": "obj_sec_2"
        },
        {
          "id": "ep_4",
          "name": "Secondary Endpoint 4",
          "text": "Molybdenum quantified in food, drink, feces, and urine, plasma total molybdenum at ALXN1840 steady state",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacokinetic",
          "objectiveId": "obj_sec_3"
        },
        {
          "id": "ep_5",
          "name": "Secondary Endpoint 5",
          "text": "Mean daily molybdenum balance as demonstrated through measurement of molybdenum intake (in food, drink and ALXN1840), and molybdenum output (feces and urine) representing ALXN1840 steady state",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacokinetic",
          "objectiveId": "obj_sec_4"
        },
        {
          "id": "ep_6",
          "name": "Secondary Endpoint 6",
          "text": "Accumulation of molybdenum as determined by molybdenum balance",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacokinetic",
          "objectiveId": "obj_sec_5"
        },
        {
          "id": "ep_7",
          "name": "Secondary Endpoint 7",
          "text": "PK parameters for plasma total and PUF-molybdenum",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacokinetic",
          "objectiveId": "obj_sec_6"
        },
        {
          "id": "ep_8",
          "name": "Secondary Endpoint 8",
          "text": "Safety parameters: \n• Treatment emergent adverse events (TEAEs)/serious adverse events (SAEs) \n• Clinical laboratory assessments (serum chemistry, hematology, coagulation, and urinalysis) \n• Physical examinations \n• Heart rate, intervals (PR, QRS, QT and QTc), and clinically significant electrocardiogram (ECG) findings as determined by triplicate 12-lead ECG \n• Vital sign assessments (blood pressure and heart rate)",
          "level": {
            "code": "C98781",
            "codeSystem": "NCI",
            "decode": "Secondary Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Safety",
          "objectiveId": "obj_sec_7"
        },
        {
          "id": "ep_9",
          "name": "Exploratory Endpoint 9",
          "text": "Assess dose response of ALXN1840 on copper balance focusing on copper balance",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Efficacy",
          "objectiveId": "obj_exp_1"
        },
        {
          "id": "ep_10",
          "name": "Exploratory Endpoint 10",
          "text": "Determine the effect of time following initiation of ALXN1840 treatment on copper balance",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Efficacy",
          "objectiveId": "obj_exp_2"
        },
        {
          "id": "ep_11",
          "name": "Exploratory Endpoint 11",
          "text": "Ceruloplasmin, ceruloplasmin-bound copper, and LBC: Change in ceruloplasmin at Days 1, 8, 25, 29, 36, and Day 39 compared with predose",
          "level": {
            "code": "C98724",
            "codeSystem": "NCI",
            "decode": "Exploratory Objective"
          },
          "instanceType": "Endpoint",
          "purpose": "Pharmacodynamic",
          "objectiveId": "obj_exp_3"
        }
      ],
      "studyInterventions": [
        {
          "id": "int_1",
          "name": "ALXN1840",
          "role": {
            "code": "Investigational Product",
            "codeSystem": "USDM",
            "decode": "Investigational Product"
          },
          "instanceType": "StudyIntervention",
          "description": "ALXN1840 (bis-choline tetrathiomolybdate) is a novel copper binding agent in development for the treatment of Wilson disease (WD).",
          "productIds": [
            "prod_1"
          ],
          "administrationIds": [
            "admin_1"
          ]
        },
        {
          "id": "int_2",
          "name": "Paracetamol/acetaminophen",
          "role": {
            "code": "Concomitant Medication",
            "codeSystem": "USDM",
            "decode": "Concomitant Medication"
          },
          "instanceType": "StudyIntervention",
          "description": "Permitted for use as an exception with the approval of the Investigator.",
          "administrationIds": [
            "admin_2"
          ]
        },
        {
          "id": "int_3",
          "name": "Ibuprofen",
          "role": {
            "code": "Concomitant Medication",
            "codeSystem": "USDM",
            "decode": "Concomitant Medication"
          },
          "instanceType": "StudyIntervention",
          "description": "Permitted for use with caution with approval of the Investigator.",
          "administrationIds": [
            "admin_3"
          ]
        }
      ]
    }
  ],
  "administrableProducts": [
    {
      "id": "prod_1",
      "name": "ALXN1840",
      "instanceType": "AdministrableProduct",
      "doseForm": {
        "code": "Tablet",
        "codeSystem": "USDM",
        "decode": "Tablet"
      },
      "strength": "15 mg",
      "substanceIds": [
        "sub_1"
      ],
      "manufacturer": "Alexion"
    }
  ],
  "administrations": [
    {
      "id": "admin_1",
      "name": "ALXN1840 initial dose",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "once daily",
      "route": {
        "code": "Oral",
        "codeSystem": "USDM",
        "decode": "Oral"
      },
      "duration": "Approximately 28 days (Day 1 through Day 28)"
    },
    {
      "id": "admin_2",
      "name": "ALXN1840 titrated dose",
      "instanceType": "Administration",
      "dose": "30 mg",
      "doseFrequency": "once daily",
      "route": {
        "code": "Oral",
        "codeSystem": "USDM",
        "decode": "Oral"
      },
      "duration": "From Day 29 through Day 39"
    },
    {
      "id": "admin_3",
      "name": "ALXN1840 dose reduction",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "every other day",
      "route": {
        "code": "Oral",
        "codeSystem": "USDM",
        "decode": "Oral"
      },
      "duration": "Dose modification for individual participants based on safety events."
    },
    {
      "id": "admin_4",
      "name": "Paracetamol/acetaminophen",
      "instanceType": "Administration",
      "dose": "maximum 1000 mg",
      "doseFrequency": "per day",
      "route": {
        "code": "Oral",
        "codeSystem": "USDM",
        "decode": "Oral"
      },
      "duration": "As needed"
    },
    {
      "id": "admin_5",
      "name": "Ibuprofen",
      "instanceType": "Administration",
      "dose": "not to exceed 1200 mg",
      "doseFrequency": "in any 24-hour period",
      "route": {
        "code": "Oral",
        "codeSystem": "USDM",
        "decode": "Oral"
      },
      "duration": "As needed"
    }
  ],
  "substances": [
    {
      "id": "sub_1",
      "name": "bis-choline tetrathiomolybdate",
      "instanceType": "Substance",
      "description": "Active ingredient of ALXN1840."
    },
    {
      "id": "sub_2",
      "name": "Paracetamol",
      "instanceType": "Substance",
      "description": "Allowed concomitant medication."
    },
    {
      "id": "sub_3",
      "name": "Acetaminophen",
      "instanceType": "Substance",
      "description": "Allowed concomitant medication."
    },
    {
      "id": "sub_4",
      "name": "Ibuprofen",
      "instanceType": "Substance",
      "description": "Allowed concomitant medication."
    }
  ],
  "narrativeContents": [
    {
      "id": "nc_1",
      "name": "PROTOCOL SUMMARY",
      "order": 0,
      "instanceType": "NarrativeContent",
      "sectionNumber": "1",
      "sectionTitle": "PROTOCOL SUMMARY",
      "sectionType": {
        "code": "Synopsis",
        "codeSystem": "USDM",
        "decode": "Synopsis"
      },
      "childIds": [
        "nci_1_1",
        "nci_1_2",
        "nci_1_3"
      ]
    },
    {
      "id": "nc_2",
      "name": "INTRODUCTION",
      "order": 1,
      "instanceType": "NarrativeContent",
      "sectionNumber": "2",
      "sectionTitle": "INTRODUCTION",
      "sectionType": {
        "code": "Introduction",
        "codeSystem": "USDM",
        "decode": "Introduction"
      },
      "childIds": [
        "nci_2_1",
        "nci_2_2",
        "nci_2_3"
      ]
    },
    {
      "id": "nc_3",
      "name": "OBJECTIVES AND ENDPOINTS",
      "order": 2,
      "instanceType": "NarrativeContent",
      "sectionNumber": "3",
      "sectionTitle": "OBJECTIVES AND ENDPOINTS",
      "sectionType": {
        "code": "Objectives",
        "codeSystem": "USDM",
        "decode": "Objectives"
      }
    },
    {
      "id": "nc_4",
      "name": "STUDY DESIGN",
      "order": 3,
      "instanceType": "NarrativeContent",
      "sectionNumber": "4",
      "sectionTitle": "STUDY DESIGN",
      "sectionType": {
        "code": "Study Design",
        "codeSystem": "USDM",
        "decode": "Study Design"
      },
      "childIds": [
        "nci_4_1",
        "nci_4_2",
        "nci_4_3",
        "nci_4_4"
      ]
    },
    {
      "id": "nc_5",
      "name": "STUDY POPULATION",
      "order": 4,
      "instanceType": "NarrativeContent",
      "sectionNumber": "5",
      "sectionTitle": "STUDY POPULATION",
      "sectionType": {
        "code": "Study Population",
        "codeSystem": "USDM",
        "decode": "Study Population"
      },
      "childIds": [
        "nci_5_1",
        "nci_5_2",
        "nci_5_3",
        "nci_5_4"
      ]
    },
    {
      "id": "nc_6",
      "name": "STUDY INTERVENTION",
      "order": 5,
      "instanceType": "NarrativeContent",
      "sectionNumber": "6",
      "sectionTitle": "STUDY INTERVENTION",
      "sectionType": {
        "code": "Treatment",
        "codeSystem": "USDM",
        "decode": "Treatment"
      }
    },
    {
      "id": "nc_7",
      "name": null,
      "order": 6,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10",
      "sectionType": {
        "code": "Other",
        "codeSystem": "USDM",
        "decode": "Other"
      },
      "childIds": [
        "nci_7_1",
        "nci_7_2",
        "nci_7_3",
        "nci_7_4",
        "nci_7_5",
        "nci_7_6",
        "nci_7_7"
      ]
    },
    {
      "id": "nc_8",
      "name": "REFERENCES",
      "order": 7,
      "instanceType": "NarrativeContent",
      "sectionNumber": "11",
      "sectionTitle": "REFERENCES",
      "sectionType": {
        "code": "References",
        "codeSystem": "USDM",
        "decode": "References"
      }
    }
  ],
  "abbreviations": [
    {
      "id": "abbr_1",
      "abbreviatedText": "SoA",
      "expandedText": "Schedule of Activities",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_2",
      "abbreviatedText": "SARS-CoV-2",
      "expandedText": "Coronavirus",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_3",
      "abbreviatedText": "AE",
      "expandedText": "Adverse Events",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_4",
      "abbreviatedText": "SAE",
      "expandedText": "Serious Adverse Event",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_5",
      "abbreviatedText": "COVID-19",
      "expandedText": "Coronavirus Disease 2019",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_6",
      "abbreviatedText": "WD",
      "expandedText": "Wilson disease",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_7",
      "abbreviatedText": "ADME",
      "expandedText": "absorption, distribution, metabolism, and excretion",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_8",
      "abbreviatedText": "NCC",
      "expandedText": "non-ceruloplasmin-bound copper",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_9",
      "abbreviatedText": "NCCcorrected",
      "expandedText": "non-ceruloplasmin-bound copper (NCC) corrected",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_10",
      "abbreviatedText": "TPC",
      "expandedText": "tetrathiomolybdate- copper -albumin tripartite complex",
      "instanceType": "Abbreviation"
    },
    {
      "id": "abbr_11",
      "abbreviatedText": "PK",
      "expandedText": "pharmacokinetics",
      "instanceType": "Abbreviation"
    }
  ],
  "studyDefinitionDocument": {
    "id": "sdd_1",
    "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "3.1",
    "versionDate": "2022-03-18",
    "contentIds": [
      "nc_1",
      "nc_2",
      "nc_3",
      "nc_4",
      "nc_5",
      "nc_6",
      "nc_7",
      "nc_8"
    ]
  },
  "studyAmendments": [
    {
      "id": "amend_1",
      "number": "3.1 (US)",
      "scope": {
        "code": "Global",
        "codeSystem": "USDM",
        "decode": "Global"
      },
      "instanceType": "StudyAmendment",
      "summary": "Clarified study procedures for US sites to facilitate recruitment, including allowing some sites to perform only screening procedures. Aligned the zinc discontinuation period from 30 to 21 days for consistency within the protocol.",
      "effectiveDate": "2022-03-18",
      "reasonIds": [
        "ar_1_1",
        "ar_1_2"
      ],
      "previousVersion": "3",
      "newVersion": "3.1 (US)"
    },
    {
      "id": "amend_2",
      "number": "3",
      "scope": {
        "code": "Global",
        "codeSystem": "USDM",
        "decode": "Global"
      },
      "instanceType": "StudyAmendment",
      "effectiveDate": "2021-08-31",
      "previousVersion": "2",
      "newVersion": "3"
    },
    {
      "id": "amend_3",
      "number": "2",
      "scope": {
        "code": "Global",
        "codeSystem": "USDM",
        "decode": "Global"
      },
      "instanceType": "StudyAmendment",
      "effectiveDate": "2021-03-19",
      "previousVersion": "1",
      "newVersion": "2"
    },
    {
      "id": "amend_4",
      "number": "1",
      "scope": {
        "code": "Global",
        "codeSystem": "USDM",
        "decode": "Global"
      },
      "instanceType": "StudyAmendment",
      "effectiveDate": "2020-08-18",
      "previousVersion": "Original",
      "newVersion": "1"
    }
  ],
  "geographicScope": {
    "id": "geo_1",
    "name": "Study Geographic Scope",
    "scopeType": "Multinational",
    "instanceType": "GeographicScope",
    "countryIds": [
      "country_1"
    ],
    "regions": [
      "North America",
      "Europe"
    ]
  },
  "countries": [
    {
      "id": "country_1",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "issues_found"
  }
}